当前位置:
X-MOL 学术
›
N. Engl. J. Med.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Improving the Outcome of Bad-Acting Hormone Receptor–Positive Breast Cancer
The New England Journal of Medicine ( IF 96.2 ) Pub Date : 2024-10-31 , DOI: 10.1056/nejme2411229 William J. GradisharFrom the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago.
The New England Journal of Medicine ( IF 96.2 ) Pub Date : 2024-10-31 , DOI: 10.1056/nejme2411229 William J. GradisharFrom the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago.
The treatment approach for patients with estrogen receptor–positive, human epidermal growth factor receptor 2 (HER2)–negative metastatic breast cancer has changed dramatically over the past 20 year...
中文翻译:
改善不良作用激素受体阳性乳腺癌的预后
在过去的 20 年里,雌激素受体阳性、人表皮生长因子受体 2 (HER2) 阴性转移性乳腺癌患者的治疗方法发生了巨大变化。
更新日期:2024-10-31
中文翻译:
改善不良作用激素受体阳性乳腺癌的预后
在过去的 20 年里,雌激素受体阳性、人表皮生长因子受体 2 (HER2) 阴性转移性乳腺癌患者的治疗方法发生了巨大变化。